ORPHA:1321
Camptodactyly-fibrous tissue hyperplasia-skeletal anomalies syndrome
Also known as: Goodman camptodactyly
Publications
387
82.4th percentile
Trials
0
Interventional, condition-specific
Researchers
1,242
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
An extremely rare chondrodysplastic syndrome characterized by the combination of arachnodactyly, becoming evident at around the age of 10, camptodactyly, and scoliosis. Additional reported manifestations include a mild and a mild facial dysmorphism including a broad nose and flaring nostrils. There have been no further descriptions in the literature since 1972.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0008900
- MeSH:C537974
- OMIM:211930
- UMLS:C5848327
Additional Mondo synonyms (1)
camptodactyly with fibrous tissue hyperplasia and skeletal dysplasia
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
387 matched papers (258 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
387
387 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
387 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
258 in the last 10 years · medium confidence · 82.4th percentile (publications denominator)
Phrase hits: 387 · MeSH hits: 0
Who's working on it?
1,242
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Li H7 papers · 2026
Department of Osteopathy, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China.
Papers in Europe PMC - 02Liu Y7 papers · 2026
Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, P.R. China.
Papers in Europe PMC - 03Wang Y7 papers · 2025
Department of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. wangyanspinejoint@163.com.
Papers in Europe PMC - 04Zhang Y6 papers · 2023
Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
Papers in Europe PMC - 05Whyte MP5 papers · 2023
Metabolic Research Unit, Shriners Hospital for Children, St. Louis, Missouri 63131, USA.
Papers in Europe PMC - 06Zhang J5 papers · 2026
Department of Orthopaedics, The Affiliated Hospital of Innermongolia Medical University, Hohhot, 010010, China.
Papers in Europe PMC - 07Chai W4 papers · 2025
Department of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. chaiwei301@163.com.
Papers in Europe PMC - 08Kodera Y4 papers · 2025
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Papers in Europe PMC - 09Li Y4 papers · 2023
Department of Orthopaedics, Beijing Chao-Yang Hospital, China Capital Medical University, Beijing, 100020, China.
Papers in Europe PMC - 10Sun J4 papers · 2022
Department of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
medium confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Camptodactyly-fibrous tissue hyperplasia-skeletal anomalies syndrome" OR "Goodman camptodactyly" OR "camptodactyly with fibrous tissue hyperplasia and skeletal dysplasia"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Camptodactyly-fibrous tissue hyperplasia-skeletal anomalies syndrome" OR "Goodman camptodactyly" OR "camptodactyly with fibrous tissue hyperplasia and skeletal dysplasia"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (387) is high for prevalence class "<1 / 1 000 000" — confidence capped at medium
Ingested 2026-07-26T17:02:16.624Z